Vonoprazan–Amoxicillin Dual Therapy With Different Amoxicillin Administration Regimens for Helicobacter pylori Treatment: A Randomized Controlled Trial

阿莫西林 医学 餐后 幽门螺杆菌 不利影响 内科学 加药 胃肠病学 抗生素 微生物学 生物 胰岛素
作者
Shuhan Qiu,Yu Huang,Biaohua Chen,Yixian Guo,Meixuan Li,Zhaohui Ding,Xiao Liang,Hong Lü
出处
期刊:Helicobacter [Wiley]
卷期号:29 (4) 被引量:1
标识
DOI:10.1111/hel.13118
摘要

ABSTRACT Background The effect of preprandial or postprandial administration of amoxicillin on the efficacy of vonoprazan–amoxicillin dual therapy (VA‐dual therapy) for Helicobacter pylori treatment has not been studied. It is also unclear whether amoxicillin dosing four times daily is more effective than three times daily. We aimed to investigate the effect of different amoxicillin administration regimens on the efficacy of VA‐dual therapy. Materials and Methods H. pylori ‐infected subjects were randomly assigned to three groups in a 1:1:1 ratio to receive a 14‐day dual therapy consisting of vonoprazan 20 mg twice daily + amoxicillin 1000 mg three times daily before meals (BM‐TID) or 1000 mg three times daily after meals (AM‐TID) or 750 mg four times daily after meals (AM‐QID). H. pylori eradication rates, adverse events rates, compliance, and antibiotic resistance were compared. Results Between May 2021 to April 2023, 327 subjects were enrolled. The eradication rates of BM‐TID, AM‐TID, and AM‐QID dual therapy were 88.1%, 89.9%, and 93.6% in intention‐to‐treat (ITT) analysis, 90.6%, 94.2%, and 99.0% in modified ITT (MITT) analysis, and 90.4%, 94.1%, and 99.0% in per‐protocol (PP) analysis. Although there was non‐inferiority between BM‐TID and AM‐TID, as well as between AM‐TID and AM‐QID, AM‐QID was significantly more effective than BM‐TID. There were no significant differences in adverse event rates, compliance, and antibiotic resistance among the three groups. Conclusions Postprandial administration and the increased frequency of administration of amoxicillin may contribute to a better efficacy of VA‐dual therapy, especially for rescue therapy. All VA‐dual therapy in our study could achieve good efficacy for first‐line treatment. Trial Registration: clinicaltrials.gov : NCT05901051.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
wanci应助wangdafa采纳,获得10
1秒前
竹子co完成签到,获得积分10
1秒前
steventj完成签到,获得积分10
1秒前
yz完成签到 ,获得积分10
2秒前
朴实山兰完成签到,获得积分10
3秒前
tkkdy发布了新的文献求助10
3秒前
蓁蓁发布了新的文献求助10
3秒前
醉熏的鑫发布了新的文献求助10
4秒前
独家双层汉堡完成签到,获得积分10
4秒前
Li完成签到,获得积分10
5秒前
xcx发布了新的文献求助10
5秒前
江小小发布了新的文献求助10
6秒前
6秒前
乐乐乐乐乐乐应助大橙子采纳,获得10
6秒前
伍六七完成签到,获得积分10
7秒前
shinen发布了新的文献求助10
7秒前
文艺的又亦完成签到,获得积分10
7秒前
小蘑菇应助妍儿采纳,获得10
8秒前
9秒前
义气天真完成签到,获得积分10
9秒前
满意易蓉发布了新的文献求助10
10秒前
10秒前
303完成签到 ,获得积分10
11秒前
海阔光明完成签到,获得积分10
11秒前
酷波er应助樾苒采纳,获得10
11秒前
Bingo完成签到,获得积分10
12秒前
hhhh完成签到 ,获得积分10
12秒前
小Q完成签到,获得积分10
13秒前
wangdafa发布了新的文献求助10
13秒前
wjq泉完成签到 ,获得积分20
14秒前
Zfy完成签到 ,获得积分10
14秒前
村医完成签到,获得积分10
14秒前
自然怀寒完成签到,获得积分10
15秒前
15秒前
yar应助西西采纳,获得10
15秒前
迅速泽洋完成签到,获得积分10
15秒前
orixero应助祭天丶易木采纳,获得10
16秒前
tkkdy完成签到,获得积分10
16秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds第二卷 1200
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038657
求助须知:如何正确求助?哪些是违规求助? 3576306
关于积分的说明 11375198
捐赠科研通 3306108
什么是DOI,文献DOI怎么找? 1819379
邀请新用户注册赠送积分活动 892698
科研通“疑难数据库(出版商)”最低求助积分说明 815066